Organon & Co.
NYSE:OGN
14.94 (USD) • At close February 4, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|
Assets: | ||||||
Current Assets: | ||||||
Cash & Cash Equivalents
| 693 | 706 | 737 | 500 | 319 | 244 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 693 | 706 | 737 | 500 | 319 | 244 |
Net Receivables
| 1,744 | 1,475 | 1,382 | 1,090 | 1,560 | 1,593 |
Inventory
| 1,315 | 1,003 | 915 | 913 | 1,071 | 994 |
Other Current Assets
| 756 | 747 | 726 | 1,552 | 1,005 | 883 |
Total Current Assets
| 4,508 | 3,931 | 3,760 | 3,434 | 3,955 | 3,714 |
Non-Current Assets: | ||||||
Property, Plant & Equipment, Net
| 1,183 | 1,018 | 973 | 984 | 680 | 651 |
Goodwill
| 4,603 | 4,603 | 4,603 | 4,603 | 4,603 | 4,603 |
Intangible Assets
| 533 | 649 | 651 | 503 | 569 | 812 |
Goodwill and Intangible Assets
| 5,136 | 5,252 | 5,254 | 5,106 | 5,172 | 5,415 |
Long Term Investments
| 0 | 0 | -4 | 0 | 0 | 0 |
Tax Assets
| 0 | 19 | 4 | 0 | 0 | 0 |
Other Non-Current Assets
| 1,231 | 735 | 694 | 910 | 741 | 714 |
Total Non-Current Assets
| 7,550 | 7,024 | 6,921 | 7,000 | 6,593 | 6,780 |
Total Assets
| 12,058 | 10,955 | 10,681 | 10,434 | 10,548 | 10,494 |
Liabilities & Equity: | ||||||
Current Liabilities: | ||||||
Account Payables
| 1,314 | 1,132 | 1,382 | 259 | 258 | 289 |
Short Term Debt
| 9 | 8 | 9 | 16 | 34 | -207 |
Tax Payables
| 206 | 184 | 185 | 109 | 242 | 322 |
Deferred Revenue
| 0 | 19 | 0 | -8 | 0 | 322 |
Other Current Liabilities
| 1,389 | 1,188 | 1,021 | 2,289 | 807 | 497 |
Total Current Liabilities
| 2,918 | 2,512 | 2,597 | 1,201 | 1,341 | 1,545 |
Non-Current Liabilities: | ||||||
Long Term Debt
| 8,876 | 9,055 | 9,309 | 46 | 70 | 34 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | -23 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 47 | 19 | 4 | 121 | 139 | 149 |
Other Non-Current Liabilities
| 287 | 261 | 279 | 1,904 | 1,963 | 2,567 |
Total Non-Current Liabilities
| 9,210 | 9,335 | 9,592 | 10,053 | 2,172 | 2,601 |
Total Liabilities
| 12,128 | 11,847 | 12,189 | 11,254 | 3,513 | 4,146 |
Equity: | ||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 3 | 3 | 3 | 3 | 7,949 | 7,256 |
Retained Earnings
| 443 | -331 | -998 | -219 | 0 | 0 |
Accumulated Other Comprehensive Income/Loss
| -541 | -564 | -513 | -604 | -914 | -908 |
Other Total Stockholders Equity
| 25 | 0 | 0 | 0 | 0 | 0 |
Total Shareholders Equity
| -70 | -892 | -1,508 | -820 | 7,035 | 6,348 |
Total Equity
| -70 | -892 | -1,508 | -820 | 7,035 | 6,348 |
Total Liabilities & Shareholders Equity
| 12,058 | 10,955 | 10,681 | 10,434 | 10,548 | 10,494 |